Elucid Bioimaging Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
1
Ending by 2030
Feb 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 13, 2026The maintenance fee for Non-Invasive Quantitative Imaging Biomarkers of Atherosclerotic Plaque Biology (US 11,676,359) comes due Dec 13, 2026. Unpaid by Jun 14, 2027, it lapses early.
- 1 fee due Jan 11, 2027The maintenance fee for Quantitative imaging for instantaneous wave-free ratio (US 11,696,735) comes due Jan 11, 2027. Unpaid by Jul 12, 2027, it lapses early.
- 1 fee due Feb 1, 2027The maintenance fee for Extended Tissue Types for Increased Granularity in Cardiovascular Disease Phenotyping (US 11,715,187) comes due Feb 1, 2027. Unpaid by Aug 2, 2027, it lapses early.
- 5 fees due Jul 9 to 30, 2027 · next Jul 9
Recent changes
- 1 of the patents on this record was granted since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,235,887 | Classification of Biological Tissue by Multi-Mode Data Registration, Segmentation and Characterization In force · High confidence | In force | High confidence | |
| US 11,607,179 | Non-Invasive Risk Stratification for Atherosclerosis In force · Low confidence | In force | Low confidence | |
| US 11,676,359 | Non-Invasive Quantitative Imaging Biomarkers of Atherosclerotic Plaque Biology In force · High confidence | In force | High confidence | |
| US 12,039,765 | Systems and Methods for Optimizing Analysis of CT Angiography In force · Medium confidence | In force | Medium confidence | |
| US 12,045,983 | Functional Measures of Stenosis Significance In force · Medium confidence | In force | Medium confidence | |
| US 12,073,561 | Multiscale modeling to determine molecular profiles from radiology In force · From the USPTO record | In force | From the USPTO record | |
| US 12,106,477 | Segmenting Permeability, Neovascularization, Necrosis, Collagen Breakdown, or Inflammation to Characterize Atherosclerotic Plaque, Coronary Artery Disease, or Vasculopathy In force · Medium confidence | In force | Medium confidence | |
| US 12,131,471 | Longitudinal Change Measures for Optimizing Patient Care In force · Medium confidence | In force | Medium confidence | |
| US 12,131,472 | Non-Invasive Imaging to Determine Health and Disease In force · Medium confidence | In force | Medium confidence | |
| US 12,136,214 | Non-Invasive Imaging to Inform Patient Care In force · Medium confidence | In force | Medium confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
14 pending · 3 abandoned · 2 no status recorded